Efficacy News and Research

RSS
Rivaroxaban safer, effective than standard therapy in treating PE

Rivaroxaban safer, effective than standard therapy in treating PE

Study clarifies conflicting reports for clot aspiration and abciximab administration

Study clarifies conflicting reports for clot aspiration and abciximab administration

FDA issues Complete Response letter to MAP's NDA for LEVADEX

FDA issues Complete Response letter to MAP's NDA for LEVADEX

Medtronic Resolute DES found effective through two years

Medtronic Resolute DES found effective through two years

CardioFocus introduces HeartLight Endoscopic Ablation System for AF in the Netherlands

CardioFocus introduces HeartLight Endoscopic Ablation System for AF in the Netherlands

CSL Behring commences enrollment in SCIg PATH trial for CIDP

CSL Behring commences enrollment in SCIg PATH trial for CIDP

FDA approves Teva's QNASL nasal aerosol corticosteroid

FDA approves Teva's QNASL nasal aerosol corticosteroid

Theracurmin shows positive impact on human diastolic functions

Theracurmin shows positive impact on human diastolic functions

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Promising results from Esperion ETC-1002 Phase 2 clinical trial for dyslipidemia

Multifaceted intervention improves use of evidence-based medicines

Multifaceted intervention improves use of evidence-based medicines

Results from Merck's vorapaxar study on cardiovascular events

Results from Merck's vorapaxar study on cardiovascular events

Largest study to date to look at BMC therapy in patients with heart failure

Largest study to date to look at BMC therapy in patients with heart failure

New embolization procedure may bring hope to men with enlarged prostate

New embolization procedure may bring hope to men with enlarged prostate

Medtronic announces results from two Symplicity system trials on treatment-resistant hypertension

Medtronic announces results from two Symplicity system trials on treatment-resistant hypertension

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

Combination of everolimus and exemestane reduces spread of cancer in the bone

Combination of everolimus and exemestane reduces spread of cancer in the bone

FDA clears multiple enhancements to St. Jude Medical's FFR measurement guidewire

FDA clears multiple enhancements to St. Jude Medical's FFR measurement guidewire

China SFDA approves Taibang's clinical trials for human fibrinogen

China SFDA approves Taibang's clinical trials for human fibrinogen

State roundup: Union seeks $80M from N.Y. for health aides' insurance

State roundup: Union seeks $80M from N.Y. for health aides' insurance

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.